FOX 13's Allie Corey sat down with the chief of surgical oncology at TGH Institute and professor of surgery at USF Health as ...
Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in ...
Novocure said on Monday its experimental therapy extended the lives of patients with a form of advanced pancreatic cancer ...
Patients with locally advanced pancreatic cancer demonstrated a two-month difference in survival with tumor-treating fields ...
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers, with a survival rate of just 11%. A primary culprit behind this grim statistic is its immunosuppressive tumor microenvironment ...
Novocure’s positive phase 3 results boost pancreatic cancer treatment prospects. Read why NVCR stock is worth watching with ...
NovoCure's TTFields therapy, combined with standard chemotherapy, improves overall survival in advanced pancreatic cancer.
Mark Spain, who was an evening anchor at Action News Jax from 2007 to 2014, revealed in a post on his professional Facebook ...
There's no routine screening test for pancreatic cancer, and symptoms can be mistaken for common illnesses.
The phase 3 PANOVA-3 trial, designed to evaluate concomitant treatment with tumor treating fields and chemotherapy, met its ...
Novocure stock soars 49% as the late-stage study of TTFields therapy for treating pancreatic adenocarcinoma meets the primary ...
Cancer researchers at Fox Chase Cancer Center see promise in personalized medicine to help crack the code on improving diagnosis and treatment options for pancreatic cancer.